Notify me when BIOS Fund I, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ACTU | Actuate Therapeutics, Inc. | Common Stock, par value $0.000001 per share | 50% | $112,734,207 | +$1,733,259 | 10,267,232 | +1.6% | AARON G.L. FLETCHER | 27 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|